For instance, NIS-mediated radioiodine therapy for estrogen receptor-negative BC has been studied in more detail [24], and Kelkar MG recently reported that histone deacetylase inhibitors (HDACis) as modulators of NIS expression can significantly increase NIS expression but do not alter its intracellular localization. This evidence concerns the gene SLC5A5 and breast cancer.